(TheNewswire)
Vancouver, B.C. - TheNewswire - March 17, 2022 – Solarvest BioEnergy Inc.(“Solarvest", or the "Company")(TSXV:SVS), (“Solarvest” or the“Company”), announces that it has been granted a patent in Japan. The intellectual property protection concentrates on the productionof algal biomass, algal cell cultures, lipid compounds, andcompositions thereof, including fatty acids, carotenoids, andfat-soluble vitamins. This patent adds additional strength to theCompany’s existing patent portfolio as it commercializes its line oforganic Omega-3 products.
According to the Principal Company survey “Accordingto the survey, 35.1% of Japanese consumers “currently use”supplements. This is higher among women and the elderly population,with about 45% of women above 50 using supplements. The professionalcommunity in Asia is starting to take many of these products to helpwith weight management and nutritional deficiencies that come withtheir less active lifestyles.”
“The marketplace is begging for nutritionalsupplements that meet the needs of these people. Companies like GNCand Nature Made are just starting to tap the Far East Asian market andbring products such as probiotics, multivitamins, DHA, and fishoil”.*
After its initial product launch and further industrydiscussions, the Company has focused on supplying unique “cleanlabel” products to satisfy the demand for premium plant-based,organic Omega-3 health products. In addition, the Company’swholly-owned subsidiary Eversea has accelerated efforts to offerorganic marketing companies and organic-oriented retailershouse-branded products (often termed “white label”) based on ourunique bioavailable Omega-3 ingredient. Channel marketing feedbackindicates that there is extensive market demand for the product’sunique characteristics, particularly among consumers focused onorganic and vegan diets. The Company’s patented Omega-3 activeingredient has obtained FDA NDI (New Dietary Ingredient) certificationand is USDA and EU Organic Certified.
AboutSolarvest
Solarvest BioEnergy Inc. is an algaebiologics company whose production platform provides it with anextremely flexible system capable of producing numerous products fromOmega 3 fatty acids to human therapeutic proteins. The Company hassuccessfully developed, patented, and produced the world's onlyplant-based organic certified Omega-3 to satisfy the substantialdemand for this essential nutrient. The Company has also initiated aprogram for the expression of CBD and THC to be produced in GMPfermentation facilities.
For further information contact:
Gerri Greenham, Chief Executive Officer
Phone: (647) 204-4095
Email: invest@solarvest.ca
Forward-Looking Information
This press release contains"forward-looking information" within the meaning ofapplicable Canadian securities legislation. Forward-lookinginformation includes, but is not limited to, statements with respectto the terms of the Offering, the completion of the Offering, and theexpected use of the net proceeds received by the Company. Generally,forward-looking information can be identified by the use offorward-looking terminology such as "plans","expects" or "does not expect", "isexpected", "budget", "scheduled","estimates", "forecasts", "intends","anticipates" or "does not anticipate", or"believes", or variations of such words and phrases or statethat certain actions, events or results "may","could", "would", "might" or "willbe taken", "occur" or "be achieved".Forward-looking information is subject to known and unknown risks,uncertainties, and other factors that may cause the actual results,level of activity, performance, or achievements of the Company to bematerially different from those expressed or implied by suchforward-looking information, including but not limited to: generalbusiness, economic, competitive, geopolitical and socialuncertainties; and regulatory risks. Although the Company hasattempted to identify important factors that could cause actualresults to differ materially from those contained in forward-lookinginformation, there may be other factors that cause results not to beas anticipated, estimated, or intended. There can be no assurance thatsuch information will prove to be accurate, as actual results andfuture events could differ materially from those anticipated in suchstatements. Accordingly, readers should not place undue reliance onforward-looking information. The forward-looking information containedin this news release is expressly qualified in its entirety by thiscautionary statement. The Company does not undertake to update anyforward-looking information, except as required by applicablesecurities laws.
Neither the TSX Venture Exchange nor its regulation servicesprovider (as that term is defined in the policies of the TSX VentureExchange) accepts responsibility for the adequacy or accuracy of thispress release.
None of thesecurities of Solarvest have been registered under the U.S. SecuritiesAct of 1933, as amended (the “U.S. Securities Act”), or any statesecurities law, and may not be offered or sold in the United States orto, or for the account or benefit of, persons in the United States or“ U.S.persons " (as such term is defined in Regulation S under the U.S.Securities Act) absent registration or an exemption from suchregistration requirements. This press release shall not constitute anoffer to sell or the solicitation of an offer to buy in the UnitedStates nor shall there be any sale of the securities in any State inwhich such offer, solicitation, or sale would beunlawful.
* Breaking into the HealthFood and Supplement Market in Japan(principle-c.com)
Copyright (c) 2022 TheNewswire - All rights reserved.